Outcomes with P2Y12 inhibitors after PCI according to CYP2C19 genotype
This video was recorded in response to a recent publication in Cir Cardiovasc Interven. by Danny Claassens and colleagues.
Danny Claassens is a PhD candidate at the department of Cardiology at Isala Hospital in the Netherlands
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: